<?xml version="1.0" encoding="UTF-8" standalone="no"?><document id="DDI-DrugBank.d291">
    <sentence id="DDI-DrugBank.d291.s0" text="When Bezalip or Bezalip retard is used at the same time as other medicines or substances the following interactions must be taken into account: - Bezalip and Bezalip retard may enhance the action of anticoagulants of the coumarin type.">
        <entity charOffset="5-11" id="DDI-DrugBank.d291.s0.e0" text="Bezalip" type="brand"/>
        <entity charOffset="16-29" id="DDI-DrugBank.d291.s0.e1" text="Bezalip retard" type="brand"/>
        <entity charOffset="146-152" id="DDI-DrugBank.d291.s0.e2" text="Bezalip" type="brand"/>
        <entity charOffset="158-171" id="DDI-DrugBank.d291.s0.e3" text="Bezalip retard" type="brand"/>
        <entity charOffset="199-233" id="DDI-DrugBank.d291.s0.e4" text="anticoagulants of the coumarin type" type="group"/>
        <pair ddi="false" e1="DDI-DrugBank.d291.s0.e0" e2="DDI-DrugBank.d291.s0.e1" id="DDI-DrugBank.d291.s0.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d291.s0.e0" e2="DDI-DrugBank.d291.s0.e2" id="DDI-DrugBank.d291.s0.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d291.s0.e0" e2="DDI-DrugBank.d291.s0.e3" id="DDI-DrugBank.d291.s0.p2"/>
        <pair ddi="false" e1="DDI-DrugBank.d291.s0.e0" e2="DDI-DrugBank.d291.s0.e4" id="DDI-DrugBank.d291.s0.p3"/>
        <pair ddi="false" e1="DDI-DrugBank.d291.s0.e1" e2="DDI-DrugBank.d291.s0.e2" id="DDI-DrugBank.d291.s0.p4"/>
        <pair ddi="false" e1="DDI-DrugBank.d291.s0.e1" e2="DDI-DrugBank.d291.s0.e3" id="DDI-DrugBank.d291.s0.p5"/>
        <pair ddi="false" e1="DDI-DrugBank.d291.s0.e1" e2="DDI-DrugBank.d291.s0.e4" id="DDI-DrugBank.d291.s0.p6"/>
        <pair ddi="false" e1="DDI-DrugBank.d291.s0.e2" e2="DDI-DrugBank.d291.s0.e3" id="DDI-DrugBank.d291.s0.p7"/>
        <pair ddi="true" e1="DDI-DrugBank.d291.s0.e2" e2="DDI-DrugBank.d291.s0.e4" id="DDI-DrugBank.d291.s0.p8" type="effect"/>
        <pair ddi="true" e1="DDI-DrugBank.d291.s0.e3" e2="DDI-DrugBank.d291.s0.e4" id="DDI-DrugBank.d291.s0.p9" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d291.s1" text="For this reason, the dose of the anticoagulant should be reduced by 30 - 50% at the start of treatment with Bezalip or Bezalip retard and then titrated according to the blood clotting parameters">
        <entity charOffset="33-45" id="DDI-DrugBank.d291.s1.e0" text="anticoagulant" type="drug"/>
        <entity charOffset="108-114" id="DDI-DrugBank.d291.s1.e1" text="Bezalip" type="brand"/>
        <entity charOffset="119-125" id="DDI-DrugBank.d291.s1.e2" text="Bezalip" type="brand"/>
        <pair ddi="true" e1="DDI-DrugBank.d291.s1.e0" e2="DDI-DrugBank.d291.s1.e1" id="DDI-DrugBank.d291.s1.p0" type="advise"/>
        <pair ddi="true" e1="DDI-DrugBank.d291.s1.e0" e2="DDI-DrugBank.d291.s1.e2" id="DDI-DrugBank.d291.s1.p1" type="advise"/>
        <pair ddi="false" e1="DDI-DrugBank.d291.s1.e1" e2="DDI-DrugBank.d291.s1.e2" id="DDI-DrugBank.d291.s1.p2"/>
    </sentence>
    <sentence id="DDI-DrugBank.d291.s2" text="."/>
    <sentence id="DDI-DrugBank.d291.s3" text="- The action of sulphonylureas and insulin may be enhanced by Bezalip or Bezalip retard.">
        <entity charOffset="16-29" id="DDI-DrugBank.d291.s3.e0" text="sulphonylureas" type="group"/>
        <entity charOffset="35-41" id="DDI-DrugBank.d291.s3.e1" text="insulin" type="drug"/>
        <entity charOffset="62-68" id="DDI-DrugBank.d291.s3.e2" text="Bezalip" type="brand"/>
        <entity charOffset="73-86" id="DDI-DrugBank.d291.s3.e3" text="Bezalip retard" type="brand"/>
        <pair ddi="false" e1="DDI-DrugBank.d291.s3.e0" e2="DDI-DrugBank.d291.s3.e1" id="DDI-DrugBank.d291.s3.p0"/>
        <pair ddi="true" e1="DDI-DrugBank.d291.s3.e0" e2="DDI-DrugBank.d291.s3.e2" id="DDI-DrugBank.d291.s3.p1" type="effect"/>
        <pair ddi="true" e1="DDI-DrugBank.d291.s3.e0" e2="DDI-DrugBank.d291.s3.e3" id="DDI-DrugBank.d291.s3.p2" type="effect"/>
        <pair ddi="true" e1="DDI-DrugBank.d291.s3.e1" e2="DDI-DrugBank.d291.s3.e2" id="DDI-DrugBank.d291.s3.p3" type="effect"/>
        <pair ddi="true" e1="DDI-DrugBank.d291.s3.e1" e2="DDI-DrugBank.d291.s3.e3" id="DDI-DrugBank.d291.s3.p4" type="effect"/>
        <pair ddi="false" e1="DDI-DrugBank.d291.s3.e2" e2="DDI-DrugBank.d291.s3.e3" id="DDI-DrugBank.d291.s3.p5"/>
    </sentence>
    <sentence id="DDI-DrugBank.d291.s4" text="This may be due to an improved glucose utilization with simultaneous reduction in insulin requirement">
        <entity charOffset="82-88" id="DDI-DrugBank.d291.s4.e0" text="insulin" type="drug"/>
    </sentence>
    <sentence id="DDI-DrugBank.d291.s5" text="."/>
    <sentence id="DDI-DrugBank.d291.s6" text="- In isolated cases, a pronounced though reversible, impairment of renal function (accompanied by a corresponding increase in the serum creatinine level) has been reported in organ transplant patients receiving immuno-suppressant therapy and concomitant bezafibrate.">
        <entity charOffset="211-228" id="DDI-DrugBank.d291.s6.e0" text="immuno-suppressant" type="group"/>
        <entity charOffset="254-264" id="DDI-DrugBank.d291.s6.e1" text="bezafibrate" type="drug"/>
        <pair ddi="true" e1="DDI-DrugBank.d291.s6.e0" e2="DDI-DrugBank.d291.s6.e1" id="DDI-DrugBank.d291.s6.p0" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d291.s7" text="Accordingly, renal function should be closely monitored in these patients and, in the event of relevant significant changes in laboratory parameters, bezafibrate should, if necessary, be discontinued">
        <entity charOffset="150-160" id="DDI-DrugBank.d291.s7.e0" text="bezafibrate" type="drug"/>
    </sentence>
    <sentence id="DDI-DrugBank.d291.s8" text="."/>
    <sentence id="DDI-DrugBank.d291.s9" text="- When Bezalip or Bezalip retard is used concurrently with anion-exchange resins (e.g. cholestryramine), an interval of at least 2 hours should be maintained between the two medicines, since the absorption of Bezalip or Bezalip retard is impaired">
        <entity charOffset="7-13" id="DDI-DrugBank.d291.s9.e0" text="Bezalip" type="brand"/>
        <entity charOffset="18-31" id="DDI-DrugBank.d291.s9.e1" text="Bezalip retard" type="brand"/>
        <entity charOffset="59-79" id="DDI-DrugBank.d291.s9.e2" text="anion-exchange resins" type="group"/>
        <entity charOffset="87-101" id="DDI-DrugBank.d291.s9.e3" text="cholestryramine" type="drug"/>
        <entity charOffset="209-215" id="DDI-DrugBank.d291.s9.e4" text="Bezalip" type="brand"/>
        <entity charOffset="220-233" id="DDI-DrugBank.d291.s9.e5" text="Bezalip retard" type="brand"/>
        <pair ddi="false" e1="DDI-DrugBank.d291.s9.e0" e2="DDI-DrugBank.d291.s9.e1" id="DDI-DrugBank.d291.s9.p0"/>
        <pair ddi="true" e1="DDI-DrugBank.d291.s9.e0" e2="DDI-DrugBank.d291.s9.e2" id="DDI-DrugBank.d291.s9.p1" type="advise"/>
        <pair ddi="true" e1="DDI-DrugBank.d291.s9.e0" e2="DDI-DrugBank.d291.s9.e3" id="DDI-DrugBank.d291.s9.p2" type="advise"/>
        <pair ddi="false" e1="DDI-DrugBank.d291.s9.e0" e2="DDI-DrugBank.d291.s9.e4" id="DDI-DrugBank.d291.s9.p3"/>
        <pair ddi="false" e1="DDI-DrugBank.d291.s9.e0" e2="DDI-DrugBank.d291.s9.e5" id="DDI-DrugBank.d291.s9.p4"/>
        <pair ddi="true" e1="DDI-DrugBank.d291.s9.e1" e2="DDI-DrugBank.d291.s9.e2" id="DDI-DrugBank.d291.s9.p5" type="advise"/>
        <pair ddi="true" e1="DDI-DrugBank.d291.s9.e1" e2="DDI-DrugBank.d291.s9.e3" id="DDI-DrugBank.d291.s9.p6" type="advise"/>
        <pair ddi="false" e1="DDI-DrugBank.d291.s9.e1" e2="DDI-DrugBank.d291.s9.e4" id="DDI-DrugBank.d291.s9.p7"/>
        <pair ddi="false" e1="DDI-DrugBank.d291.s9.e1" e2="DDI-DrugBank.d291.s9.e5" id="DDI-DrugBank.d291.s9.p8"/>
        <pair ddi="false" e1="DDI-DrugBank.d291.s9.e2" e2="DDI-DrugBank.d291.s9.e3" id="DDI-DrugBank.d291.s9.p9"/>
        <pair ddi="false" e1="DDI-DrugBank.d291.s9.e2" e2="DDI-DrugBank.d291.s9.e4" id="DDI-DrugBank.d291.s9.p10"/>
        <pair ddi="false" e1="DDI-DrugBank.d291.s9.e2" e2="DDI-DrugBank.d291.s9.e5" id="DDI-DrugBank.d291.s9.p11"/>
        <pair ddi="false" e1="DDI-DrugBank.d291.s9.e3" e2="DDI-DrugBank.d291.s9.e4" id="DDI-DrugBank.d291.s9.p12"/>
        <pair ddi="false" e1="DDI-DrugBank.d291.s9.e3" e2="DDI-DrugBank.d291.s9.e5" id="DDI-DrugBank.d291.s9.p13"/>
        <pair ddi="false" e1="DDI-DrugBank.d291.s9.e4" e2="DDI-DrugBank.d291.s9.e5" id="DDI-DrugBank.d291.s9.p14"/>
    </sentence>
    <sentence id="DDI-DrugBank.d291.s10" text="."/>
    <sentence id="DDI-DrugBank.d291.s11" text="- Perhexiline hydrogen maleate or MAO-inhibitors (with hepatotoxic potential) must not be administered together with Bezalip or Bezalip retard.">
        <entity charOffset="2-29" id="DDI-DrugBank.d291.s11.e0" text="Perhexiline hydrogen maleate" type="drug"/>
        <entity charOffset="34-47" id="DDI-DrugBank.d291.s11.e1" text="MAO-inhibitors" type="group"/>
        <entity charOffset="117-123" id="DDI-DrugBank.d291.s11.e2" text="Bezalip" type="brand"/>
        <entity charOffset="128-141" id="DDI-DrugBank.d291.s11.e3" text="Bezalip retard" type="brand"/>
        <pair ddi="false" e1="DDI-DrugBank.d291.s11.e0" e2="DDI-DrugBank.d291.s11.e1" id="DDI-DrugBank.d291.s11.p0"/>
        <pair ddi="true" e1="DDI-DrugBank.d291.s11.e0" e2="DDI-DrugBank.d291.s11.e2" id="DDI-DrugBank.d291.s11.p1" type="advise"/>
        <pair ddi="true" e1="DDI-DrugBank.d291.s11.e0" e2="DDI-DrugBank.d291.s11.e3" id="DDI-DrugBank.d291.s11.p2" type="advise"/>
        <pair ddi="true" e1="DDI-DrugBank.d291.s11.e1" e2="DDI-DrugBank.d291.s11.e2" id="DDI-DrugBank.d291.s11.p3" type="advise"/>
        <pair ddi="true" e1="DDI-DrugBank.d291.s11.e1" e2="DDI-DrugBank.d291.s11.e3" id="DDI-DrugBank.d291.s11.p4" type="advise"/>
        <pair ddi="false" e1="DDI-DrugBank.d291.s11.e2" e2="DDI-DrugBank.d291.s11.e3" id="DDI-DrugBank.d291.s11.p5"/>
    <negationtags>- Perhexiline hydrogen maleate or MAO-inhibitors (with hepatotoxic potential) must &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; be administered together with Bezalip or Bezalip retard. &lt;/scope&gt;</negationtags></sentence>
</document>